🇺🇸 FDA
Pipeline program

HPV DNA Plasmids Therapeutic Vaccine VGX-3100

AMC-103

Phase 2 mab completed

Quick answer

HPV DNA Plasmids Therapeutic Vaccine VGX-3100 for Anal Intraepithelial Neoplasia is a Phase 2 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Anal Intraepithelial Neoplasia
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials